Reference Data
| Compound | Fladrafinil |
|---|---|
| Also Known As | CRL-40,941 / Fluorafinil / Bisfluoroadrafinil |
| Strength | 50MG per capsule |
| Count | 60 capsules |
| Total Content | 3,000MG Fladrafinil |
| Format | Capsule research product |
| Manufacturing Standard | GMP |
| Research Category | Afinil analog / CNS pathway / monoamine-associated research |
| Research Focus | Afinil-analog research, benzhydryl sulfinyl compound models, wakefulness-associated pathway research, monoamine-associated signaling, CNS pathway studies, neurochemical response models, and compound-response screening. |
Reference figures are provided for research identification. Always confirm against the batch-specific Certificate of Analysis.
50MG Fladrafinil / 3,000MG Total Content
Fladrafinil is studied in controlled laboratory models involving modafinil-adjacent compound behavior, afinil-analog pathway research, CNS response systems, monoamine-associated signaling, and neurochemical activity models.
Afinil Analog Research
Studied in models involving afinil-class analog behavior, benzhydryl sulfinyl compound systems, CNS pathway activity, and compound-response screening.
CNS Pathway Models
Relevant to laboratory investigations involving neurochemical response, wakefulness-associated pathway research, monoamine-associated signaling, and receptor-adjacent response systems.
60 Capsule Format
Clear 50MG capsule strength presentation with 60 capsules per bottle and 3,000MG total Fladrafinil content.
Why Fladrafinil Matters in Research
Fladrafinil is studied in laboratory models involving afinil-analog compound behavior, modafinil-adjacent pathway systems, monoamine-associated signaling, CNS response pathways, neurochemical activity, and wakefulness-associated research models.
Research interest in Fladrafinil centers on how CRL-40,941 may behave in controlled CNS pathway models, benzhydryl sulfinyl compound studies, neurochemical response systems, and compound-screening workflows under structured laboratory conditions.
The 50MG 60 capsule format provides researchers with a clearly labeled GMP capsule presentation containing 3,000MG total Fladrafinil for organized documentation and laboratory handling.
- 50MG Fladrafinil per capsule
- 60 capsules per bottle
- 3,000MG total Fladrafinil content
- Also known as CRL-40,941
- GMP capsule research product format
- Studied in afinil-analog and CNS pathway research
- Relevant to monoamine-associated and neurochemical response models
- Reviewed for strength clarity, capsule presentation, total-content transparency, documentation, storage expectations, and fulfillment handling
Research Applications
- Afinil-analog compound research
- Benzhydryl sulfinyl compound models
- CNS pathway studies
- Wakefulness-associated pathway research
- Monoamine-associated signaling models
- Neurochemical response research
- Compound-response screening
- Capsule-format research product studies
Why Our Quality Process Is Different
Capsule-based research products require more oversight than a simple compound listing. Strength consistency, capsule presentation, total-content transparency, documentation, label accuracy, finished-product handling, storage expectations, and fulfillment quality all matter.
Disguised Alpha reviews Fladrafinil as a complete GMP capsule research product with attention to 50MG strength presentation, 3,000MG total-content transparency, finished capsule appearance, product documentation, internal QA, labeling accuracy, and direct fulfillment accountability.
- GMP manufacturing standard
- 50MG strength labeling clarity
- 3,000MG total-content transparency
- Finished capsule presentation review
- Product documentation and labeling checks
- Storage expectation review
- Internal QA before product release
- Direct in-house fulfillment with no anonymous 3PL handling
Verify Our Claims
We believe researchers should be able to verify the standards we speak about. Learn more about the independent laboratories we work with below.
The Disguised Alpha Standard
Disguised Alpha is built around direct accountability. Every order is processed, inspected, packaged, and shipped by our in-house team instead of being passed off to a third-party logistics warehouse.
This gives us tighter control over formulation quality, fulfillment accuracy, packaging standards, storage conditions, and customer experience. Our goal is not to be the cheapest research supplier — it is to provide professionally handled compounds with real quality oversight behind them.
Fladrafinil 50MG 60 Capsules is a GMP capsule research product providing 3,000MG total Fladrafinil content for controlled laboratory investigations involving afinil-analog research, benzhydryl sulfinyl compound models, wakefulness-associated pathway research, monoamine-associated signaling, CNS pathway studies, neurochemical response models, and compound-response screening.
Each bottle contains 60 capsules with 50MG Fladrafinil per capsule. Fladrafinil, also known as CRL-40,941, Fluorafinil, or Bisfluoroadrafinil, is studied in laboratory models involving modafinil-adjacent compound behavior, afinil-analog pathway systems, CNS response pathways, monoamine-associated signaling, neurochemical activity, and controlled compound-screening workflows.
Disguised Alpha Fladrafinil is reviewed for GMP manufacturing standards, 50MG strength clarity, finished capsule presentation, 3,000MG total-content transparency, product documentation, label accuracy, internal QA, storage expectations, and direct in-house fulfillment. For laboratory research use only. Not intended for human consumption, medical use, therapeutic use, wakefulness use, stimulant use, cognitive-enhancement use, focus use, productivity use, ADHD use, narcolepsy use, fatigue use, mood-support use, athletic use, performance use, capsule oral use, supplement use, self-administration use, or the treatment, prevention, or diagnosis of any disease.
Fladrafinil (CRL-40,941) is sold strictly for laboratory and in-vitro research. It is not for human consumption, veterinary use, or any diagnostic or therapeutic application. Nothing on this page is medical, dosing, or therapeutic advice.